- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CapsoVision Inc (CV)
The CapsoVision share price today is 6.15, view NASDAQ CV stock exchange data. Track the latest CapsoVision share price with real-time updates on CV stock performance including market cap, day range, 52-week range and dividend yield. Access CV charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.03
6.52
52 wk Range
3.43
15.37
CV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.036.52
52 wk Range
3.4315.37
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.00
Upside
+62.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.00
(+62.60% Upside)
CapsoVision Inc Earnings Call Summary for Q2/2026
- Q2 revenue rose 10% YoY to $3.6M, but EPS of -$0.15 missed estimates by $0.04, triggering a 7.7% after-hours stock decline to $6.27.
- Gross margin compressed to 51% from 55% due to pricing pressure and tariffs; operating expenses surged 46% to $9.5M on R&D and public company costs.
- Management expects H2 2026 to outpace H1, with Q4 as strongest quarter; FDA clearance for AI Highlights anticipated by end of Q3 2026.
- CapsoCam Colon FDA submission delayed one quarter to Q4 2026; company maintains $100M ATM program amid $9.1M cash position and rising capital needs.
- CEO Wang cited 176K patients imaged globally, up 23% YoY, positioning AI-assisted panoramic imaging as key competitive differentiator for future growth.
Last Updated: 14-08-2026, 02:48 am
Read Full TranscriptEarnings
Latest Release
13-08-2026
EPS / Forecast
-0.15 / -0.11
Revenue / Forecast
3.6M / --
Compare CV to Peers and Sector
Metrics to compare | CV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.4x | −2.1x | −0.3x | |
PEG Ratio | −0.12 | −0.18 | 0.00 | |
Price/Book | 23.5x | 2.3x | 2.6x | |
Price / LTM Sales | 22.3x | 1.9x | 3.1x | |
Upside (Analyst Target) | 55.0% | 66.7% | 49.0% | |
Fair Value Upside | Unlock | 9.5% | 6.3% | Unlock |
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the CapsoVision (CV) Share Price Today?
The CapsoVision share price today is 6.15.
What is the current CapsoVision (CV) share price and day range?
As of 18-08-2026, the CapsoVision share price is 6.15, with a previous close of 6.45. The share price has ranged from 6.03 to 6.52 today, while the 52-week range spans from 3.43 to 15.37.
What Is the CapsoVision Market Cap?
As of today, CapsoVision market cap is 322.55M.
What Is the CapsoVision (CV) Share Price Target?
The average 12-month share price target for CapsoVision is 10.00, with a high estimate of 10 and a low estimate of 10. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +62.60% Upside potential.
What Is CapsoVision's Earnings Per Share (TTM)?
The CapsoVision EPS (TTM) is -0.62.
When Is the Next CapsoVision Earnings Date?
CapsoVision will release its next earnings report on 12-11-2026.
From a Technical Analysis Perspective, Is CV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does CapsoVision Trade On?
CapsoVision is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for CapsoVision?
The stock symbol for CapsoVision is "CV."
How Many Times Has CapsoVision Stock Split?
CapsoVision has split 0 times.
How Many Employees Does CapsoVision Have?
CapsoVision has 99 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.